Abiopharma

News list

Schultes Birgit C 🔴 sold 8.5K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006292

Full text

News bot Jan. 7, 2026, 9:06 p.m.
🔍 Schultes Birgit C (Executive)

Company: Intellia Therapeutics, Inc. (NTLA)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 8,508
Detailed Transactions and Holdings:
- Sold 8,508 shares of Common Stock at $9.21 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: false | shares_owned_after: 98,533.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
- F2: Includes 925 and 932 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.